Thermo Fisher Scientific Inc.

NYSE:TMO Stock Report

Market Cap: US$219.3b

Thermo Fisher Scientific Management

Management criteria checks 3/4

Thermo Fisher Scientific's CEO is Marc Casper, appointed in Oct 2009, has a tenure of 14.5 years. total yearly compensation is $18.98M, comprised of 9.1% salary and 90.9% bonuses, including company stock and options. directly owns 0.047% of the company’s shares, worth $102.40M. The average tenure of the management team and the board of directors is 4.4 years and 12.1 years respectively.

Key information

Marc Casper

Chief executive officer

US$19.0m

Total compensation

CEO salary percentage9.1%
CEO tenure14.5yrs
CEO ownership0.05%
Management average tenure4.4yrs
Board average tenure12.1yrs

Recent management updates

Recent updates

Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching

Apr 24
Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching

Thermo Fisher Scientific: Too Hot To Handle

Apr 15

Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)

Apr 02
Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)

We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt

Mar 12
We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt

Thermo Fisher's Bright Future Makes It A Great Buy On Weakness

Feb 06

Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results

Feb 02
Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results

Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics

Jan 16

Thermo Fisher: Downturn In Pharma And Biotech And Weak China Growth; Initiate With 'Hold'

Jan 06

Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?

Dec 29
Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?

Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?

Dec 11
Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?

Thermo Fisher Scientific: I Am Still Waiting For An Attractive Buying Opportunity.

Dec 02

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 25% Below Their Intrinsic Value Estimate

Nov 07
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 25% Below Their Intrinsic Value Estimate

My Family Is Buying A Lot More Thermo Fisher Stock

Oct 31

Thermo Fisher: An Up To 35% Undervalued Healthcare Gem I Like On Weakness

Sep 28

Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?

Sep 10
Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?

Thermo Fisher Scientific: A High-Quality Investment For Double-Digit Returns

Aug 28

Thermo Fisher: Cash Flow Returns On Investments Analysis

Aug 14

Calculating The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)

Jul 25
Calculating The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)

Thermo Fisher Scientific: Continuing To Add To The Fortress

Jul 09

Thermo Fisher: A Master Compounder In Healthcare

Jul 03

These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well

Jun 07
These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well

Buy Thermo Fisher, But With Caution

Jun 01

Thermo Fisher Scientific Inc.'s (NYSE:TMO) Intrinsic Value Is Potentially 25% Below Its Share Price

Apr 26
Thermo Fisher Scientific Inc.'s (NYSE:TMO) Intrinsic Value Is Potentially 25% Below Its Share Price

CEO Compensation Analysis

How has Marc Casper's remuneration changed compared to Thermo Fisher Scientific's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$19mUS$2m

US$6b

Sep 30 2023n/an/a

US$6b

Jul 01 2023n/an/a

US$6b

Apr 01 2023n/an/a

US$6b

Dec 31 2022US$28mUS$2m

US$7b

Oct 01 2022n/an/a

US$7b

Jul 02 2022n/an/a

US$7b

Apr 02 2022n/an/a

US$8b

Dec 31 2021US$21mUS$2m

US$8b

Oct 02 2021n/an/a

US$9b

Jul 03 2021n/an/a

US$9b

Apr 03 2021n/an/a

US$8b

Dec 31 2020US$26mUS$2m

US$6b

Sep 26 2020n/an/a

US$5b

Jun 27 2020n/an/a

US$4b

Mar 28 2020n/an/a

US$4b

Dec 31 2019US$19mUS$2m

US$4b

Sep 28 2019n/an/a

US$4b

Jun 29 2019n/an/a

US$4b

Mar 30 2019n/an/a

US$3b

Dec 31 2018US$19mUS$1m

US$3b

Sep 29 2018n/an/a

US$3b

Jun 30 2018n/an/a

US$2b

Mar 31 2018n/an/a

US$2b

Dec 31 2017US$22mUS$1m

US$2b

Compensation vs Market: Marc's total compensation ($USD18.98M) is above average for companies of similar size in the US market ($USD13.52M).

Compensation vs Earnings: Marc's compensation has been consistent with company performance over the past year.


CEO

Marc Casper (55 yo)

14.5yrs

Tenure

US$18,976,669

Compensation

Mr. Marc N. Casper has been the Chief Executive Officer and President of Thermo Fisher Scientific, Inc. since October 15, 2009 and has been its Chairman of the Board of Directors since February 26, 2020. M...


Leadership Team

NamePositionTenureCompensationOwnership
Marc Casper
Chairman14.5yrsUS$18.98m0.047%
$ 102.4m
Stephen Williamson
Senior VP & CFO8.7yrsUS$6.24m0.010%
$ 22.2m
Michel Lagarde
Executive VP & COO2.3yrsUS$7.25m0.0026%
$ 5.8m
Lisa Britt
Chief Human Resources Officer & Senior VP7.1yrsUS$2.89m0.0045%
$ 10.0m
Gianluca Pettiti
Executive Vice Presidentno dataUS$5.73m0.0030%
$ 6.6m
Joseph Holmes
VP & Chief Accounting Officer3.1yrsno data0.00042%
$ 921.2k
Ryan Snyder
Senior VP & Chief Information Officer4.8yrsno datano data
Karen Nelson
Chief Scientific Officer2.7yrsno datano data
Rafael Tejada
Vice President of Investor Relationsno datano datano data
Michael Boxer
Senior VP & General Counsel6.3yrsUS$3.12m0.0033%
$ 7.2m
Sandy Pound
VP & Chief Communications Officer3.5yrsno datano data
Paul Parker
Senior Vice President of Strategy & Corporate Development4yrsno datano data

4.4yrs

Average Tenure

55yo

Average Age

Experienced Management: TMO's management team is considered experienced (4.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Marc Casper
Chairman14.5yrsUS$18.98m0.047%
$ 102.4m
Scott Sperling
Independent Lead Director17.4yrsUS$403.12k0.023%
$ 51.1m
C. Harris
Independent Director & Member of Scientific Advisory Board12.1yrsUS$325.72k0.0020%
$ 4.5m
Nelson Chai
Independent Director13.3yrsUS$365.72k0.0035%
$ 7.8m
Lars Sorensen
Independent Director7.9yrsUS$345.72k0.0024%
$ 5.2m
Mark Stevenson
Member of Scientific Advisory Boardno dataUS$9.40mno data
Tyler Jacks
Member of Scientific Advisory Board & Director14.9yrsUS$345.72k0.0020%
$ 4.4m
Cynthia Wolberger
Member of Scientific Advisory Board6.4yrsno datano data
William Hahn
Member of Scientific Advisory Boardno datano datano data
Debora Spar
Independent Director4.6yrsUS$345.72k0.00021%
$ 460.6k
Steven Gygi
Member of Scientific Advisory Boardno datano datano data
Dion Weisler
Independent Director7.1yrsUS$353.19k0.0015%
$ 3.4m

12.1yrs

Average Tenure

60yo

Average Age

Experienced Board: TMO's board of directors are seasoned and experienced ( 12.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.